• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

揭示乳腺癌免疫微环境的作用:窥探充满希望的前沿领域。

Unveiling the Immune Microenvironment's Role in Breast Cancer: A Glimpse into Promising Frontiers.

机构信息

Physiology Laboratory, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.

出版信息

Int J Mol Sci. 2023 Oct 18;24(20):15332. doi: 10.3390/ijms242015332.

DOI:10.3390/ijms242015332
PMID:37895012
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10607694/
Abstract

Breast cancer (BC), one of the most widespread and devastating diseases affecting women worldwide, presents a significant public health challenge. This review explores the emerging frontiers of research focused on deciphering the intricate interplay between BC cells and the immune microenvironment. Understanding the role of the immune system in BC is critical as it holds promise for novel therapeutic approaches and precision medicine strategies. This review delves into the current literature regarding the immune microenvironment's contribution to BC initiation, progression, and metastasis. It examines the complex mechanisms by which BC cells interact with various immune cell populations, including tumor-infiltrating lymphocytes (TILs) and tumor-associated macrophages (TAMs). Furthermore, this review highlights the impact of immune-related factors, such as cytokines and immune checkpoint molecules. Additionally, this comprehensive analysis sheds light on the potential biomarkers associated with the immune response in BC, enabling early diagnosis and prognostic assessment. The therapeutic implications of targeting the immune microenvironment are also explored, encompassing immunotherapeutic strategies and combination therapies to enhance treatment efficacy. The significance of this review lies in its potential to pave the way for novel therapeutic interventions, providing clinicians and researchers with essential knowledge to design targeted and personalized treatment regimens for BC patients.

摘要

乳腺癌(BC)是全球范围内最广泛和最具破坏性的女性疾病之一,是一个重大的公共健康挑战。本综述探讨了研究的新兴前沿领域,重点是破译 BC 细胞与免疫微环境之间复杂的相互作用。了解免疫系统在 BC 中的作用至关重要,因为它为新的治疗方法和精准医学策略提供了希望。本综述深入探讨了关于免疫微环境对 BC 发生、进展和转移的贡献的现有文献。它检查了 BC 细胞与各种免疫细胞群(包括肿瘤浸润淋巴细胞(TILs)和肿瘤相关巨噬细胞(TAMs))相互作用的复杂机制。此外,本综述强调了免疫相关因素(如细胞因子和免疫检查点分子)的影响。此外,这项全面的分析揭示了与 BC 中免疫反应相关的潜在生物标志物,从而能够进行早期诊断和预后评估。还探讨了针对免疫微环境的治疗意义,包括免疫治疗策略和联合治疗,以提高治疗效果。本综述的意义在于它有可能为新的治疗干预措施铺平道路,为临床医生和研究人员提供设计针对 BC 患者的靶向和个性化治疗方案的必要知识。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7cd/10607694/9e96691d3a8b/ijms-24-15332-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7cd/10607694/d1e0f3abf11b/ijms-24-15332-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7cd/10607694/6940459d95d1/ijms-24-15332-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7cd/10607694/9e96691d3a8b/ijms-24-15332-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7cd/10607694/d1e0f3abf11b/ijms-24-15332-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7cd/10607694/6940459d95d1/ijms-24-15332-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7cd/10607694/9e96691d3a8b/ijms-24-15332-g003.jpg

相似文献

1
Unveiling the Immune Microenvironment's Role in Breast Cancer: A Glimpse into Promising Frontiers.揭示乳腺癌免疫微环境的作用:窥探充满希望的前沿领域。
Int J Mol Sci. 2023 Oct 18;24(20):15332. doi: 10.3390/ijms242015332.
2
Immune Infiltrates in Breast Cancer: Recent Updates and Clinical Implications.乳腺癌中的免疫浸润:最新进展及临床意义。
Cells. 2021 Jan 23;10(2):223. doi: 10.3390/cells10020223.
3
The association between immune cells and breast cancer: insights from Mendelian randomization and meta-analysis.免疫细胞与乳腺癌之间的关联:孟德尔随机化和荟萃分析的见解
Int J Surg. 2025 Jan 1;111(1):230-241. doi: 10.1097/JS9.0000000000001840.
4
Future perspectives in melanoma research : Meeting report from the "Melanoma Bridge". Napoli, December 1st-4th 2015.黑色素瘤研究的未来展望:“黑色素瘤桥梁”会议报告。那不勒斯,2015年12月1日至4日
J Transl Med. 2016 Nov 15;14(1):313. doi: 10.1186/s12967-016-1070-y.
5
Antiestrogens in combination with immune checkpoint inhibitors in breast cancer immunotherapy.抗雌激素药物联合免疫检查点抑制剂在乳腺癌免疫治疗中的应用。
J Steroid Biochem Mol Biol. 2019 Oct;193:105415. doi: 10.1016/j.jsbmb.2019.105415. Epub 2019 Jun 19.
6
Ki67 and lymphocytes in the pretherapeutic core biopsy of primary invasive breast cancer: positive markers of therapy response prediction and superior survival.原发性浸润性乳腺癌治疗前核心活检中的Ki67和淋巴细胞:治疗反应预测的阳性标志物及更好的生存率
Horm Mol Biol Clin Investig. 2017 Sep 22;32(2):/j/hmbci.2017.32.issue-2/hmbci-2017-0022/hmbci-2017-0022.xml. doi: 10.1515/hmbci-2017-0022.
7
Targeting the immune microenvironment for ovarian cancer therapy.针对卵巢癌治疗的免疫微环境。
Front Immunol. 2023 Dec 18;14:1328651. doi: 10.3389/fimmu.2023.1328651. eCollection 2023.
8
The molecular mechanism of actions and clinical utilities of tumor infiltrating lymphocytes in gastrointestinal cancers: a comprehensive review and future prospects toward personalized medicine.胃肠道癌症中肿瘤浸润淋巴细胞的作用机制及临床应用:全面综述及对个性化医学的未来展望。
Front Immunol. 2023 Nov 24;14:1298891. doi: 10.3389/fimmu.2023.1298891. eCollection 2023.
9
Chimeric antigen receptor-based immunotherapy in breast cancer: Recent progress in China.嵌合抗原受体免疫疗法在乳腺癌中的研究进展:中国的最新进展。
Cancer. 2024 Apr 15;130(S8):1378-1391. doi: 10.1002/cncr.35096. Epub 2023 Nov 11.
10
Cyclic Multiplexed-Immunofluorescence (cmIF), a Highly Multiplexed Method for Single-Cell Analysis.循环多重免疫荧光(cmIF),一种用于单细胞分析的高度多重化方法。
Methods Mol Biol. 2020;2055:521-562. doi: 10.1007/978-1-4939-9773-2_24.

引用本文的文献

1
Immune profiling in oncology: bridging the gap between technology and treatment.肿瘤学中的免疫分析:弥合技术与治疗之间的差距。
Med Oncol. 2025 Aug 26;42(10):446. doi: 10.1007/s12032-025-03002-x.
2
Key players in the breast cancer microenvironment: From fibroblasts to immune cells.乳腺癌微环境中的关键参与者:从成纤维细胞到免疫细胞。
World J Clin Oncol. 2025 Jul 24;16(7):107339. doi: 10.5306/wjco.v16.i7.107339.
3
Integrative transcriptomic and single-cell analysis reveals IL27RA as a key immune regulator and therapeutic indicator in breast cancer.

本文引用的文献

1
Prospect of neoadjuvant/adjuvant immunotherapy in early-stage triple-negative breast cancer.早期三阴性乳腺癌新辅助/辅助免疫治疗的前景
Transl Breast Cancer Res. 2023 Jan 31;4:6. doi: 10.21037/tbcr-23-4. eCollection 2023.
2
Impact of endocrine disruptors on peripheral blood mononuclear cells in vitro: role of gender.内分泌干扰物对体外外周血单核细胞的影响:性别作用。
Arch Toxicol. 2023 Dec;97(12):3129-3150. doi: 10.1007/s00204-023-03592-3. Epub 2023 Sep 7.
3
Decoding the Complexity of Immune-Cancer Cell Interactions: Empowering the Future of Cancer Immunotherapy.
整合转录组学和单细胞分析揭示IL27RA是乳腺癌中的关键免疫调节因子和治疗指标。
Discov Oncol. 2025 Jun 1;16(1):977. doi: 10.1007/s12672-025-02811-w.
4
Soft matrix promotes immunosuppression in tumor-resident immune cells via COX-FGF2 signaling.软基质通过COX-FGF2信号通路促进肿瘤驻留免疫细胞中的免疫抑制。
Nat Commun. 2025 May 27;16(1):4908. doi: 10.1038/s41467-025-60092-x.
5
A global bibliometric and visualized analysis of the status and trends of lung metastasis in breast cancer research from 2000 to 2024.2000年至2024年乳腺癌研究中肺转移状况与趋势的全球文献计量及可视化分析
Discov Oncol. 2025 May 8;16(1):700. doi: 10.1007/s12672-025-02496-1.
6
Reprogramming the breast tumor immune microenvironment: cold-to-hot transition for enhanced immunotherapy.重编程乳腺肿瘤免疫微环境:从冷到热的转变以增强免疫治疗
J Exp Clin Cancer Res. 2025 Apr 25;44(1):131. doi: 10.1186/s13046-025-03394-8.
7
MRI analysis of relative tumor enhancement in liver metastases and correlation with immunohistochemical features.肝脏转移瘤相对肿瘤强化的MRI分析及其与免疫组化特征的相关性。
Insights Imaging. 2024 Dec 5;15(1):294. doi: 10.1186/s13244-024-01866-7.
8
Special Issue: "Molecular Signatures of Gynecological Cancers-Breast Cancer, Ovarian Cancer, Cervical Cancer, and Endometrial Cancer 2.0".特刊:“妇科癌症的分子特征-乳腺癌、卵巢癌、宫颈癌和子宫内膜癌 2.0”。
Int J Mol Sci. 2024 Oct 20;25(20):11275. doi: 10.3390/ijms252011275.
9
Breast cancer immunotherapy: Realities and advances.乳腺癌免疫疗法:现状与进展
Cancer Innov. 2024 Sep 22;3(5):e140. doi: 10.1002/cai2.140. eCollection 2024 Oct.
10
Decoding the Role of Insulin-like Growth Factor 1 and Its Isoforms in Breast Cancer.解析胰岛素样生长因子 1 及其异构体在乳腺癌中的作用。
Int J Mol Sci. 2024 Aug 27;25(17):9302. doi: 10.3390/ijms25179302.
解读免疫细胞与癌细胞相互作用的复杂性:助力癌症免疫治疗的未来发展。
Cancers (Basel). 2023 Aug 21;15(16):4188. doi: 10.3390/cancers15164188.
4
Immune Biomarkers in Triple-Negative Breast Cancer: Improving the Predictivity of Current Testing Methods.三阴性乳腺癌中的免疫生物标志物:提高当前检测方法的预测性
J Pers Med. 2023 Jul 23;13(7):1176. doi: 10.3390/jpm13071176.
5
The expression profiles of signature genes from CD103LAG3 tumour-infiltrating lymphocyte subsets predict breast cancer survival.CD103+LAG3−和 CD103−LAG3+肿瘤浸润淋巴细胞亚群的特征基因表达谱可预测乳腺癌患者的生存情况。
BMC Med. 2023 Jul 24;21(1):268. doi: 10.1186/s12916-023-02960-1.
6
Targeting DNA repair for cancer treatment: Lessons from PARP inhibitor trials.针对癌症治疗的 DNA 修复:PARP 抑制剂试验的经验教训。
Oncol Res. 2023 Jun 27;31(4):405-421. doi: 10.32604/or.2023.028310. eCollection 2023.
7
Prediction of Tumor Progression During Neoadjuvant Chemotherapy and Survival Outcome in Patients With Triple-Negative Breast Cancer.三阴性乳腺癌患者新辅助化疗期间肿瘤进展及生存结局的预测。
Korean J Radiol. 2023 Jul;24(7):626-639. doi: 10.3348/kjr.2022.0974.
8
Eligibility criteria in clinical trials in breast cancer: a cohort study.乳腺癌临床试验的入选标准:一项队列研究。
BMC Med. 2023 Jul 3;21(1):240. doi: 10.1186/s12916-023-02947-y.
9
Beyond CTLA-4 and PD-1 Inhibition: Novel Immune Checkpoint Molecules for Melanoma Treatment.超越CTLA-4和PD-1抑制:用于黑色素瘤治疗的新型免疫检查点分子
Cancers (Basel). 2023 May 11;15(10):2718. doi: 10.3390/cancers15102718.
10
Early-Stage Triple-Negative Breast Cancer Journey: Beginning, End, and Everything in Between.早期三阴性乳腺癌之旅:起点、终点及其间的一切。
Am Soc Clin Oncol Educ Book. 2023 Jun;43:e390464. doi: 10.1200/EDBK_390464.